Annalise Weckesser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Annalise Weckesser has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Elaine Denny
Faculty of Health, Education and Life Sciences, Birmingham City University, Birmingham, UK
8 shared publications Elaine Denny
Affiliation Faculty of Health, Education and Life Sciences, Birmingham City University, Birmingham, United Kingdom
4 shared publications- Georgina Louise Jones
Psychology Department, School of Humanities and Social Sciences, City Campus, Leeds Beckett University, Leeds, UK
3 shared publications - Jane Daniels
Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK
3 shared publications - Judith Dyson
School of Nursing and Midwifery Birmingham City University Birmingham UK
3 shared publications - Mairead Black
Aberdeen Centre for Women’s Health Research, University of Aberdeen, Aberdeen, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Taylor & Francis in Women's Reproductive Health
- p. 1-14
What We Live and Breathe: Expert Insights on Inclusivity in U.K. Period Poverty Initiatives
In the United Kingdom, at least 10% of girls are affected by period poverty (Plan International UK, 2018), broadly defined as limited access to menstrual products, education, and healthcare due to ...
- 22 July 2026
- Published by Taylor & Francis in Women's Reproductive Health
- p. 1-14
Open AccessWhat We Live and Breathe: Expert Insights on Inclusivity in U.K. Period Poverty Initiatives
In the United Kingdom, at least 10% of girls are affected by period poverty (Plan International UK, 2018), broadly defined as limited access to menstrual products, education, and healthcare due to ...
- Open Access
- 22 July 2026
- Published by Taylor & Francis in Women's Reproductive Health
- p. 1-18
Missing Out: A Qualitative Study Exploring Adolescents’ and Young Women’s Experiences of Endometriosis
Endometriosis is a chronic systemic disease (Taylor et al., 2021), in which endometrial-like tissue found outside of the uterine cavity (most commonly on the reproductive organs, bowel, and bladder...
- 22 July 2026
- Published by Taylor & Francis in Women's Reproductive Health
- p. 1-18
Open AccessMissing Out: A Qualitative Study Exploring Adolescents’ and Young Women’s Experiences of Endometriosis
Endometriosis is a chronic systemic disease (Taylor et al., 2021), in which endometrial-like tissue found outside of the uterine cavity (most commonly on the reproductive organs, bowel, and bladder...
- 1 February 2026
- Published by Bristol University Press in Journal of Poverty and Social Justice
- Vol. 34 (1) , 18-37
Same shit, different crisis? Feminist activism against period poverty during the Covid-19 pandemic in the UK
Moments of crisis, such as the Covid-19 pandemic, the 2007 financial crisis, and the ongoing cost-of-living crisis in the United Kingdom, create unique opportunities and challenges for feminist activism. Despite increased awareness, little is known about how organisations engaged in menstrual activism responded to the increased demands of tackling ‘period poverty’ during the pandemic. This article addresses this gap through interviews and survey responses with representatives from such organisations. Findings reveal that period-poverty initiatives (1) constitute a continuation of feminist anti-austerity activism, (2) highlight the triple jeopardy faced by women, and (3) create possibilities for feminist activism that address gendered inequalities. By applying an intersectional feminist ethic-of-care lens, this article provides original insights into the challenges and opportunities organisations faced during the Covid-19 pandemic. The research underscores the necessity for policy interventions that integrate feminist principles to support period-poverty initiatives, ensuring sustainable and equitable solutions. This article contributes to the burgeoning literature on period poverty in the UK, offering implications for feminist activism, organisational practice, and policy development to mitigate gendered economic and social disparities.
- 1 February 2026
- Published by Bristol University Press in Journal of Poverty and Social Justice
- Vol. 34 (1) , 18-37
Same shit, different crisis? Feminist activism against period poverty during the Covid-19 pandemic in the UK
Moments of crisis, such as the Covid-19 pandemic, the 2007 financial crisis, and the ongoing cost-of-living crisis in the United Kingdom, create unique opportunities and challenges for feminist activism. Despite increased awareness, little is known about how organisations engaged in menstrual activism responded to the increased demands of tackling ‘period poverty’ during the pandemic. This article addresses this gap through interviews and survey responses with representatives from such organisations. Findings reveal that period-poverty initiatives (1) constitute a continuation of feminist anti-austerity activism, (2) highlight the triple jeopardy faced by women, and (3) create possibilities for feminist activism that address gendered inequalities. By applying an intersectional feminist ethic-of-care lens, this article provides original insights into the challenges and opportunities organisations faced during the Covid-19 pandemic. The research underscores the necessity for policy interventions that integrate feminist principles to support period-poverty initiatives, ensuring sustainable and equitable solutions. This article contributes to the burgeoning literature on period poverty in the UK, offering implications for feminist activism, organisational practice, and policy development to mitigate gendered economic and social disparities.
- Open Access
- 31 October 2025
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 22 (10) , e1004580
Associations between epileptic seizures in pregnancy and adverse pregnancy outcomes: A systematic review and meta-analysis
Background: Epileptic seizures during pregnancy may increase the risk of adverse pregnancy outcomes. Socioeconomic disparities in epilepsy incidence may extend to seizure control. We conducted a systematic review and meta-analysis to assess the association between epileptic seizures during pregnancy and adverse pregnancy outcomes. We also evaluated the association between socioeconomic and individual-level factors and seizure occurrence. Methods and findings: We searched MEDLINE, Embase, CINAHL, and PsycINFO databases from inception to May 2025 for observational studies on pregnant women with epileptic seizures. We compared maternal and foetal outcomes in pregnant women with and without seizures and assessed the association between seizure occurrence and socioeconomic or individual-level factors. We used the Newcastle–Ottawa Scale to assess the risk of bias of included studies. Meta-analyses using random effects model were performed to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs). From 13,381 identified publications, 25 studies (24,596 pregnancies) are included in this analysis. In pregnant women with epilepsy, women with seizures compared to those without had increased odds of caesarean birth (OR 1.62, 95% CI 1.14 to 2.30, p = 0.007), peripartum depression (OR 2.20, 95% CI 1.04 to 4.65, p = 0.04), and small for gestational age baby (OR 1.32, 95% CI 1.03 to 1.69, p = 0.03). The odds of preterm birth (OR 1.66, 95% CI 1.29 to 2.15, p < 0.001), low birthweight (OR 1.47, 95% CI 1.12 to 1.93, p = 0.006), and small for gestational age baby (OR 1.44, 95% CI 1.19 to 1.74, p < 0.001) were higher in women with seizures compared to women without epilepsy. The risk of seizures was greater in pregnant women with epilepsy with low income compared to those with higher income (OR 1.57, 95% CI 1.22 to 2.02, p < 0.001), and in women with focal epilepsy compared to those with generalised epilepsy (OR 1.84, 95% CI 1.54 to 2.20, p < 0.001). The number of studies for some outcomes was small, limiting subgroup analyses and detection of heterogeneity. Conclusion: Epileptic seizures are associated with increased risks of adverse maternal and foetal outcomes. Risk assessment to identify women with epilepsy at highest risk of seizures is needed to optimise care.
- 31 October 2025
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 22 (10) , e1004580
Open AccessAssociations between epileptic seizures in pregnancy and adverse pregnancy outcomes: A systematic review and meta-analysis
Background: Epileptic seizures during pregnancy may increase the risk of adverse pregnancy outcomes. Socioeconomic disparities in epilepsy incidence may extend to seizure control. We conducted a systematic review and meta-analysis to assess the association between epileptic seizures during pregnancy and adverse pregnancy outcomes. We also evaluated the association between socioeconomic and individual-level factors and seizure occurrence. Methods and findings: We searched MEDLINE, Embase, CINAHL, and PsycINFO databases from inception to May 2025 for observational studies on pregnant women with epileptic seizures. We compared maternal and foetal outcomes in pregnant women with and without seizures and assessed the association between seizure occurrence and socioeconomic or individual-level factors. We used the Newcastle–Ottawa Scale to assess the risk of bias of included studies. Meta-analyses using random effects model were performed to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs). From 13,381 identified publications, 25 studies (24,596 pregnancies) are included in this analysis. In pregnant women with epilepsy, women with seizures compared to those without had increased odds of caesarean birth (OR 1.62, 95% CI 1.14 to 2.30, p = 0.007), peripartum depression (OR 2.20, 95% CI 1.04 to 4.65, p = 0.04), and small for gestational age baby (OR 1.32, 95% CI 1.03 to 1.69, p = 0.03). The odds of preterm birth (OR 1.66, 95% CI 1.29 to 2.15, p < 0.001), low birthweight (OR 1.47, 95% CI 1.12 to 1.93, p = 0.006), and small for gestational age baby (OR 1.44, 95% CI 1.19 to 1.74, p < 0.001) were higher in women with seizures compared to women without epilepsy. The risk of seizures was greater in pregnant women with epilepsy with low income compared to those with higher income (OR 1.57, 95% CI 1.22 to 2.02, p < 0.001), and in women with focal epilepsy compared to those with generalised epilepsy (OR 1.84, 95% CI 1.54 to 2.20, p < 0.001). The number of studies for some outcomes was small, limiting subgroup analyses and detection of heterogeneity. Conclusion: Epileptic seizures are associated with increased risks of adverse maternal and foetal outcomes. Risk assessment to identify women with epilepsy at highest risk of seizures is needed to optimise care.
- Open Access
- 18 October 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 133, 106-113
Experiences of pregnancy and reproductive health for women living with epilepsy: A systematic review
- 18 October 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 133, 106-113
Open AccessExperiences of pregnancy and reproductive health for women living with epilepsy: A systematic review
- Open Access
- 10 March 2025
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 308, 241-250
Seizure prediction in pregnant women with epilepsy: An umbrella review of clinical practice guidelines and systematic reviews
- 10 March 2025
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 308, 241-250
Open AccessSeizure prediction in pregnant women with epilepsy: An umbrella review of clinical practice guidelines and systematic reviews
- Open Access
- 1 September 2024
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 28 (55) , 1-77
Preventing recurrence of endometriosis-related pain by means of long-acting progestogen therapy: the PRE-EMPT RCT
Background: Endometriosis affects 1 in 10 women, many of whom have surgery for persistent pain. Recurrence of symptoms following an operation is common. Although hormonal treatment can reduce this risk, there is uncertainty about the best option. Objectives: To evaluate the clinical and cost-effectiveness of long-acting progestogen therapy compared with the combined oral contraceptive pill in preventing recurrence of endometriosis-related pain and quality of life. Design: A multicentre, open, randomised trial with parallel economic evaluation. The final design was informed by a pilot study, qualitative exploration of women’s lived experience of endometriosis and a pretrial economic model. Setting: Thirty-four United Kingdom hospitals. Participants: Women of reproductive age undergoing conservative surgery for endometriosis. Interventions: Long-acting progestogen reversible contraceptive (either 150 mg depot medroxyprogesterone acetate or 52 mg levonorgestrel-releasing intrauterine system) or combined oral contraceptive pill (30 µg ethinylestradiol, 150 µg levonorgestrel). Main outcome measures: The primary outcome was the pain domain of the Endometriosis Health Profile-30 questionnaire at 36 months post randomisation. The economic evaluation estimated the cost per quality-adjusted life-years gained. Results: Four hundred and five women were randomised to receive either long-acting reversible contraceptive (N = 205) or combined oral contraceptive pill (N = 200). Pain scores improved in both groups (24 and 23 points on average) compared with preoperative values but there was no difference between the two (adjusted mean difference: −0.8, 95% confidence interval −5.7 to 4.2; p = 0.76). The long-acting reversible contraceptive group underwent fewer surgical procedures or second-line treatments compared with the combined oral contraceptive group (73 vs. 97; hazard ratio 0.67, 95% confidence interval 0.44 to 1.00). The mean adjusted quality-adjusted life-year difference between two arms was 0.043 (95% confidence interval −0.069 to 0.152) in favour of the combined oral contraceptive pill, although this cost an additional £533 (95% confidence interval 52 to 983) per woman. Limitations: Limitations include the absence of a no-treatment group and the fact that many women changed treatments over the 3 years of follow-up. Use of telephone follow-up to collect primary outcome data in those who failed to return questionnaires resulted in missing data for secondary outcomes. The COVID pandemic may have affected rates of further surgical treatment. Conclusions: At 36 months, women allocated to either intervention had comparable levels of pain, with both groups showing around a 40% improvement from presurgical levels. Although the combined oral contraceptive was cost-effective at a threshold of £20,000 per quality-adjusted life-year, the difference between the two was marginal and lower rates of repeat surgery might make long-acting reversible contraceptives preferable to some women. Future work: Future research needs to focus on evaluating newer hormonal preparations, a more holistic approach to symptom suppression and identification of biomarkers to diagnose endometriosis and its recurrence. Trial registration: This trial is registered as ISRCTN97865475. https://doi.org/10.1186/ISRCTN97865475. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 11/114/01) and is published in full in Health Technology Assessment; Vol. 28, No. 55. See the NIHR Funding and Awards website for further award information. The NIHR recognises that people have diverse gender identities, and in this report, the word ‘woman’ is used to describe patients or individuals whose sex assigned at birth was female, whether they identify as female, male or non-binary.
- 1 September 2024
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 28 (55) , 1-77
Open AccessPreventing recurrence of endometriosis-related pain by means of long-acting progestogen therapy: the PRE-EMPT RCT
Background: Endometriosis affects 1 in 10 women, many of whom have surgery for persistent pain. Recurrence of symptoms following an operation is common. Although hormonal treatment can reduce this risk, there is uncertainty about the best option. Objectives: To evaluate the clinical and cost-effectiveness of long-acting progestogen therapy compared with the combined oral contraceptive pill in preventing recurrence of endometriosis-related pain and quality of life. Design: A multicentre, open, randomised trial with parallel economic evaluation. The final design was informed by a pilot study, qualitative exploration of women’s lived experience of endometriosis and a pretrial economic model. Setting: Thirty-four United Kingdom hospitals. Participants: Women of reproductive age undergoing conservative surgery for endometriosis. Interventions: Long-acting progestogen reversible contraceptive (either 150 mg depot medroxyprogesterone acetate or 52 mg levonorgestrel-releasing intrauterine system) or combined oral contraceptive pill (30 µg ethinylestradiol, 150 µg levonorgestrel). Main outcome measures: The primary outcome was the pain domain of the Endometriosis Health Profile-30 questionnaire at 36 months post randomisation. The economic evaluation estimated the cost per quality-adjusted life-years gained. Results: Four hundred and five women were randomised to receive either long-acting reversible contraceptive (N = 205) or combined oral contraceptive pill (N = 200). Pain scores improved in both groups (24 and 23 points on average) compared with preoperative values but there was no difference between the two (adjusted mean difference: −0.8, 95% confidence interval −5.7 to 4.2; p = 0.76). The long-acting reversible contraceptive group underwent fewer surgical procedures or second-line treatments compared with the combined oral contraceptive group (73 vs. 97; hazard ratio 0.67, 95% confidence interval 0.44 to 1.00). The mean adjusted quality-adjusted life-year difference between two arms was 0.043 (95% confidence interval −0.069 to 0.152) in favour of the combined oral contraceptive pill, although this cost an additional £533 (95% confidence interval 52 to 983) per woman. Limitations: Limitations include the absence of a no-treatment group and the fact that many women changed treatments over the 3 years of follow-up. Use of telephone follow-up to collect primary outcome data in those who failed to return questionnaires resulted in missing data for secondary outcomes. The COVID pandemic may have affected rates of further surgical treatment. Conclusions: At 36 months, women allocated to either intervention had comparable levels of pain, with both groups showing around a 40% improvement from presurgical levels. Although the combined oral contraceptive was cost-effective at a threshold of £20,000 per quality-adjusted life-year, the difference between the two was marginal and lower rates of repeat surgery might make long-acting reversible contraceptives preferable to some women. Future work: Future research needs to focus on evaluating newer hormonal preparations, a more holistic approach to symptom suppression and identification of biomarkers to diagnose endometriosis and its recurrence. Trial registration: This trial is registered as ISRCTN97865475. https://doi.org/10.1186/ISRCTN97865475. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 11/114/01) and is published in full in Health Technology Assessment; Vol. 28, No. 55. See the NIHR Funding and Awards website for further award information. The NIHR recognises that people have diverse gender identities, and in this report, the word ‘woman’ is used to describe patients or individuals whose sex assigned at birth was female, whether they identify as female, male or non-binary.
- Open Access
- 10 April 2024
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 118, 38-46
Barriers and facilitators to healthcare practitioners providing care for pregnant women with epilepsy: A systematic review and narrative synthesis
- 10 April 2024
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 118, 38-46
Open AccessBarriers and facilitators to healthcare practitioners providing care for pregnant women with epilepsy: A systematic review and narrative synthesis
- Open Access
- 17 April 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (7) , 1166-1167
How to do qualitative research?
- 17 April 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (7) , 1166-1167
Open AccessHow to do qualitative research?
- Open Access
- 3 April 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (9) , 1608-1609
BJOG perspectives – qualitative research: role of theory and ethics
- 3 April 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (9) , 1608-1609
Open AccessBJOG perspectives – qualitative research: role of theory and ethics